Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.45 USD | +1.10% | +9.42% | +26.53% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.53% | 781M | |
+7.69% | 115B | |
+12.71% | 107B | |
-13.21% | 22.31B | |
-3.99% | 21.6B | |
-6.39% | 18.23B | |
-39.93% | 17.62B | |
+6.74% | 14.26B | |
+32.76% | 12.37B | |
-28.64% | 8.28B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Transcript : Wave Life Sciences Ltd. - Special Call